ABT vs. GH: Abbott Laboratories vs. Guardant Health Stock Comparison

Company Profile

Abbott Laboratories (ABT) and Guardant Health (GH) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while GH is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Guardant Health (GH) has an aggressive beta of 1.69, indicating higher sensitivity to broad-market moves, while Abbott Laboratories (ABT) is defensive at 0.53 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Abbott Laboratories (ABT) earns 9.14% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.

Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Abbott Laboratories (ABT) reports 9.75%, ranking against industry peers normally.

Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Abbott Laboratories (ABT) reports 11.66%, ranking against industry peers normally.

Profitability Metrics

Growth

Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Abbott Laboratories (ABT) at 5.67% is closer to the peer norm — faster top-line expansion for GH.

Only one side can be read here: Abbott Laboratories (ABT) reports EPS growth of -51.31%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Both Abbott Laboratories (ABT) at 1.46 and Guardant Health (GH) at 3.60 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Only one side’s leverage can be read here: Abbott Laboratories (ABT) carries debt-to-equity ratio of 0.61 against its industry range, while Guardant Health (GH) reports no figure this period.

Financial Strength Metrics

Dividends

Guardant Health (GH) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

Guardant Health (GH) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Abbott Laboratories (ABT) trades at 41.02 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.

Abbott Laboratories (ABT) at 3.95 prices around its industry’s typical P/S ratio, while Guardant Health (GH) at 15.96 clears its benchmark range — GH looks notably rich on sales.

Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Abbott Laboratories (ABT) reports 3.73, ranking against industry peers normally.

Valuation Metrics